Amarin Corp Plc (AMRN)

[HDGabor]

C-

It is due "After Committee plenary where minutes are adopted" … will be available around "May 23" and will looks something like:

3.3.3. icosapent ethyl - EMEA/H/C/005398
indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Scope: List of questions
Action: For adoption

The Committee discussed the issues identified in this application.

The Committee adopted the CHMP recommendation and scientific discussion together with the list of questions.

The "Meeting highlights" was due today and it is available: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 March 2020

Best,
G